Related Experiment Video
Updated: Feb 14, 2026

Demonstration of Cutaneous Allodynia in Association with Chronic Pelvic Pain
Published on: June 23, 2009
Chronic pain in medullary sponge kidney: a rare and never described clinical presentation
G Gambaro1, D S Goldfarb2,3, R Baccaro1
1Divisione di Nefrologia, Fondazione Policlinico Universitario A. Gemelli, Università Cattolica del Sacro Cuore, Via G. Moscati 31, 00168, Rome, Italy.
Abstract:
Medullary sponge kidney (MSK) is a cause of nephrocalcinosis, associated with hematuria, renal colic, pyelonephritis. There are rare and atypical MSK cases characterized by chronic severe pain (CP), whose features are unknown, in particular the relationship with the stone disease activity. This study analyzes a cohort of MSK-CP patients belonging to three North-America self-support Facebook groups. Patients had to self-administer an on-line questionnaire (on intensity, progression and MSK-associated conditions, stone-related disease, pain features, drug use), the Brief Pain Inventory, the Fatigue Severity Score, and Wisconsin Quality of Life (WQL) in stone formers questionnaires. Ninety-two patients with a diagnosis of MSK joined our survey. Stone rate was very high (3.1 stones per patient-year, < 15% of patients had ≤ 1 stone per year). Most patients had repeated hospitalizations for stones symptoms (p < 0.001) or pain (p < 0.005). 71% of participants referred a daily pain that interfered strongly with everyday life and quality of life (WQL mean value 29.4). 69% used pain medications daily (70% opioids). In most cases, pain was associated with stone passage, while 15% referred a sine materia pain. We showed how MSK-CP symptoms affect very negatively on the quality of life of these patients. They also have a definite risk of progressing to end-stage kidney disease. Generally, CP seems to be associated with an exceptionally high lithogenic activity, suggesting that a better and earlier metabolic treatment for stone prevention should be the first approach in these patients before mini-invasive treatments to prevent pain.
Insights
Chronic severe pain in Medullary Sponge Kidney (MSK) is linked to high stone activity and significantly impacts quality of life. Early metabolic treatment for stone prevention is crucial for MSK patients experiencing chronic pain.
Area of Science:
- Nephrology
- Urology
- Pain Medicine
Background:
- Medullary Sponge Kidney (MSK) is a congenital kidney malformation associated with nephrocalcinosis, hematuria, renal colic, and pyelonephritis.
- A subset of MSK patients experiences chronic severe pain (CP), a poorly understood condition, particularly its relationship with stone disease activity.
Purpose of the Study:
- To investigate the characteristics and impact of chronic severe pain (CP) in Medullary Sponge Kidney (MSK) patients.
- To explore the association between CP, stone disease activity, and quality of life in MSK patients.
Main Methods:
- A cohort of 92 MSK patients from North American support groups completed an online questionnaire.
- Validated instruments including the Brief Pain Inventory, Fatigue Severity Score, and Wisconsin Quality of Life (WQL) in stone formers were used.
- Data collected included pain intensity, progression, MSK-associated conditions, stone disease, and medication use.
Main Results:
- Patients experienced a high stone rate (3.1 stones/patient/year) and frequent hospitalizations for stone symptoms or pain.
- 71% reported daily pain significantly impacting daily life and quality of life (WQL mean 29.4).
- 69% used daily pain medications, with 70% using opioids; 15% had pain unrelated to stone passage.
Conclusions:
- Chronic severe pain in MSK is associated with high lithogenic activity and severely diminishes patients' quality of life.
- MSK-CP patients face a risk of progressing to end-stage kidney disease.
- Early metabolic management for stone prevention is recommended as a primary approach before considering invasive treatments for pain management.
Related Concept Videos
Chronic Kidney Disease II: Clinical Manifestations
Kidney Structure
Chronic Kidney Disease I: Introduction
Self-Presentation
Self-Presentation: Self-Monitoring and Self-Handicapping
Acute Kidney Injury III: Clinical Manifestations

